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Protein kinase C (PKC) is involved in a wide array of
cellular processes such as cell proliferation, differentiation
and apoptosis. Phosphorylation of both turn motif (TM)
and hydrophobic motif (HM) are important for PKC func-
tion. Here, we show that the mammalian target of rapa-
mycin complex 2 (mTORC2) has an important function in
phosphorylation of both TM and HM in all conventional
PKCs, novel PKCe as well as Akt. Ablation of mTORC2
components (Rictor, Sin1 or mTOR) abolished phospho-
rylation on the TM of both PKCa and Akt and HM of Akt
and decreased HM phosphorylation of PKCa. Interestingly,
the mTORC2-dependent TM phosphorylation is essential
for PKCa maturation, stability and signalling. Our study
demonstrates that mTORC2 is involved in post-transla-
tional processing of PKC by facilitating TM and HM phos-
phorylation and reveals a novel function of mTORC2 in
cellular regulation.
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Introduction
Protein kinase C (PKC) is one of the most extensively studied
kinase family and has been implicated in cell proliferation,
differentiation, apoptosis, tumour promotion and neuronal
activity (Griner and Kazanietz, 2007). On the basis of their
structure and regulation, PKCs can be categorized into con-
ventional, novel and atypical PKC (cPKC, nPKC and aPKC)
(Mellor and Parker, 1998; Toker, 1998). Both cPKCs (a, b, g)
and nPKCs (d, e, y, Z) are activated by diacylglycerol (DAG).
The cPKCs, but not the nPKCs, are also activated by calcium.
In contrast, aPKCs (z, i) are not activated by DAG, but they
have important functions in cell polarity and asymmetric cell
division (Etienne-Manneville and Hall, 2003).
In addition to regulation by intracellular second messen-
gers, PKCs are controlled by phosphorylation in the activa-
tion loop (A-loop) within the kinase domain, the turn motif
(TM) and hydrophobic motif (HM) in the C-terminal region
(Parekh et al, 2000; Newton, 2003). These modifications are
highly conserved in PKCs with the exception of the aPKCs,
which have acidic residues in the corresponding HM sites.
Phosphorylation of the activation loop is catalysed by the
3-phosphoinositide-dependent protein kinase 1 (PDK1) and is
important for PKC activity (Chou et al, 1998; Dutil et al, 1998;
Le Good et al, 1998). However, the kinase responsible for the
TM and HM phosphorylation is less clear. There is evidence
that autophosphorylation may be responsible for the TM
and HM phosphorylation, whereas the question whether
autophosphorylation is truly responsible for these two
sites in vivo still remains (Parekh et al, 2000; Newton,
2003).
Protein kinase C belongs to the AGC family, including Akt
(also known as PKB). Akt has an important function in cell
growth, proliferation and inhibition of apoptosis (Lawlor and
Alessi, 2001). A similar pattern of phosphorylation also
occurs in Akt (Alessi and Cohen, 1998). However, phospho-
rylation appears to have an important function in Akt activa-
tion. Phosphorylation of the A-loop and HM is stimulated by
growth factors through phosphatidylinositol 3-kinase (PI3K)
and directly contributes to Akt activation (Alessi et al, 1996).
In contrast, phosphorylation of the TM is not affected by
growth factors, although this phosphorylation is important
for Akt function (Bellacosa et al, 1998; Hauge et al, 2007). In
addition, phosphorylation of the HM is also associated with
Akt activation. Recent studies have shown that the mamma-
lian target of rapamycin complex 2 (mTORC2) is responsible
for Akt HM phosphorylation, whereas the TM kinase has not
been identified (Sarbassov et al, 2005).
Mammalian target of rapamycin (mTOR) is a central cell
growth controller (Hay and Sonenberg, 2004; Wullschleger
et al, 2006). mTOR exists in two different complexes,
mTORC1 and mTORC2 (Loewith et al, 2002; Sabatini,
2006). The two TOR complexes have distinct physiological
functions and are regulated differently. mTORC1 activity is
sensitive to inhibition by rapamycin, whereas mTORC2 activ-
ity is resistant at least to short-term treatment. One of the
best-characterized physiological substrates of mTORC1 is
S6K, which is also a member of the AGC kinase family.
mTORC1 phosphorylates the HM in S6K, thereby promoting
phosphorylation of the A-loop by PDK1 (Collins et al, 2003).
mTORC2 consists of mTOR, Rictor, mLST8 and Sin1
(Sabatini, 2006). Deletion of mTORC2-specific subunits,
such as Rictor or Sin1, abolishes the HM phosphorylation
of Akt but not S6K, indicating the high substrate specificity
of the two TOR complexes (Guertin et al, 2006; Jacinto
et al, 2006; Shiota et al, 2006; Yang et al, 2006). It has
also been reported that deletion of Rictor abolishes the
HM phosphorylation in PKCa (Sarbassov et al, 2004;
Guertin et al, 2006). However, the immunoprecipitated
mTORC2 can directly phosphorylate the HM in Akt but
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not PKC in vitro (Sarbassov et al, 2004, 2005). Therefore, the
exact function of mTORC2 in PKC regulation remains to be
resolved.
In this report, we discovered a novel function of mTORC2
in the regulation of PKC and Akt. In Rictor/ or Sin1/
cells, PKCa protein levels and phosphorylation are dramati-
cally decreased. We found that Rictor and Sin1 have impor-
tant functions in the TM and HM phosphorylation of cPKCs
and nPKCe and of Akt. Inhibition of mTOR by RNA inter-
ference knockdown and specific inhibitors blocks the TM and
HM phosphorylation of both PKC and Akt. Interestingly,
Rictor preferentially interacts with the unphosphorylated
PKCa, suggesting a direct role of Rictor in PKC regulation,
although we were unable to detect a direct phosphorylation
of PKC by immunoprecipitated mTORC2 in vitro. We also
observed that PKC kinase activity and substrate phospho-
rylation are impaired in Rictor/ or Sin1/ cells. The
mTORC2-dependent TM and HM phosphorylation of PKC are
critical for the kinase stability and function. Our study reveals
an essential physiological function of mTORC2 in the regula-
tion of PKC and Akt by promoting phosphorylation and
maturation of the kinases.
Results
Rictor is required for phosphorylation of TM and HM
in PKCa and Akt
To study the function of TORC2 in AGC family kinase regula-
tion, we examined Rictor/ embryos, which showed no
Rictor protein and a diminished Sin1 protein level
(Figure 1A). We found that PKCa protein level was dramati-
cally decreased in Rictor/ embryos compared with that
in Rictorþ /þ embryos, whereas S6K protein level
was unaffected (Figure 1A). Furthermore, PKCa protein
migrated significantly faster in the Rictor/ than
Rictorþ /þ embryos, suggesting that PKCa was depho-
sphorylated in the Rictor/ embryos. As expected,
phosphorylation of HM (S657) in PKCa was largely decreased
in the Rictor/ embryos (Figure 1A). In contrast,
phosphorylation of HM in S6K was intact. Previous studies
have indicated that phosphorylation of the PKCa TM is
important for protein stability (Newton, 2003). Therefore,
we examined PKCa TM (T638) phosphorylation and
found that PKCa TM phosphorylation was completely






























Figure 1 Rictor is required for TM and HM phosphorylation of PKCa and Akt. (A) Deletion of Rictor gene decreases PKCa protein levels
and phosphorylation. E10.5 embryos were lysed and used for immunoblot analysis. Immunoblotting was performed for PKCa and
S6K phosphorylation states and mTOR complex components in lysates prepared from individual Rictor þ /þ , þ / and / embryos.
(B) Phosphorylation of PKCa TM is eliminated in Rictor/ embryos. Endogenous PKCa proteins were immunoprecipitated and a similar
protein level was loaded. Phosphorylation of A-loop, TM and HM was determined by immunoblotting. (C) A-loop, TM and HM phosphoryla-
tion of transfected PKCa. HA–PKCa plasmid was transfected into Rictorþ /þ or / MEFand HA–PKCa protein was immunoprecipitated and
probed for phosphorylation. (D) Deletion of Rictor gene eliminates Akt TM and HM phosphorylation. E10.5 embryos were analysed for Akt
phosphorylation.
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observation is interesting and important because
regulation of TM phosphorylation has not been clearly
defined, although it is highly conserved in PKC and the
AGC family.
To ascertain the decreased phosphorylation of PKCa in the
Rictor/ embryos, PKCa proteins were immunoprecipi-
tated from lysates of Rictorþ /þ and / embryos, and a
similar level of PKCa was loaded. We found that phosphor-
ylation of the TM was completely abolished and HM phos-
phorylation was significantly reduced in the Rictor/
embryos (Figure 1B). Interestingly, the phosphorylation of
PKCa A-loop (T497), the PDK1 phosphorylation site, was also
diminished in Rictor/ embryos (Figure 1B). This observa-
tion was confirmed by transfection of PKCa into Rictorþ /þ
or / murine embryonic fibroblast (MEF) cells. We found
that TM phosphorylation of the ectopically expressed PKCa
was completely abolished, whereas the phosphorylation of
HM and A-loop were decreased in the Rictor/ cells
(Figure 1C). Our data indicate that Rictor is critically required
for phosphorylation of TM and is also involved in A-loop and
HM in PKCa.
To examine whether a similar regulation was operating in
Akt, we monitored Akt phosphorylation. As expected,
phosphorylation of the Akt HM (S473) was abolished in
Rictor/ embryos, whereas phosphorylation of the activa-
tion loop (A-loop, T308) was not affected (Figure 1D). It is
worth noting that Rictor deletion dramatically decreased
PKCa A-loop, but not Akt A-loop phosphorylation, although
both kinases are phosphorylated by PDK1. Therefore, the
effect of Rictor on PKCa A-loop phosphorylation might be
indirect. Interestingly, phosphorylation of the TM (T450) in
Akt was also abolished in Rictor/ embryos. Similar results
were observed in Rictor/ MEF cells (Supplementary
Figure S1). Our study provides the first strong genetic
evidence that phosphorylation of TM in both PKCa and Akt
is dependent on Rictor.
Sin1 but not PDK1 is required for TM phosphorylation
in both PKCa and Akt
We and other groups have recently identified Sin1 as an
essential subunit of mTORC2 (Frias et al, 2006; Jacinto
et al, 2006; Yang et al, 2006; Vander Haar et al, 2007).
To determine the function of Sin1 in PKC and Akt regulation,
we analysed Sin1/ MEFs. Deletion of Sin1 gene
was confirmed by the lack of Sin1 protein expression
(Figure 2A). Sin1 was also required for phosphorylation of
both the TM and HM in both PKCa and Akt (Figure 2A).
In contrast, the A-loop phosphorylation in Akt was
independent of Sin1. In addition, PKCa protein level was
also significantly decreased in Sin1/ cells. However,
lack of Sin1 had no effect on S6K or PKCd phosphorylation.
These results establish that both Rictor and Sin1 have
important functions in the phosphorylation of the TM and
HM in PKCa and Akt.
To confirm that the defect of the TM and HM phosphoryla-
tion in both PKCa and Akt was a consequence of Sin1
deletion, we reintroduced an HA-Sin1 plasmid into the
Sin1/ cells. HA-Sin1 expression partially restored TM
and HM phosphorylation of both PKCa and Akt. The partial
restorations of TM and HM phosphorylation of PKCa and Akt
are likely due to the low expression levels of HA-Sin1 protein
in Sin1/ MEF (Figure 2B).
PDK1 is an important upstream kinase for the A-loop
phosphorylation in both PKC and Akt (Mora et al, 2004).
To examine the role of A-loop phosphorylation for TM and
HM phosphorylation, we analysed PDK1/ murine em-
bryonic stem (ES) cells. As expected, phosphorylation of
the A-loop in both PKCa and Akt was abolished; however,
the TM phosphorylation was slightly affected in PDK1/ ES
cells (Figure 2C). Interestingly, the HM phosphorylation in
PKCa, but not in Akt, was abolished in PDK1/ cells,
suggesting that the regulations of HM phosphorylation in
PKCa and Akt are distinct. A possible interpretation is that A-
loop phosphorylation by PDK1 activates PKCa, which might
autophosphorylate its HM. Stimulation with insulin-like
growth factor (IGF) or inhibition of PI3K by wortmannin
caused a corresponding increase or decrease of Akt phos-
phorylation in the A-loop and HM, but not the TM
(Figure 2C). However, IGF or wortmannin had a mild effect
on PKCa phosphorylation.
To test whether PKCa TM and HM are regulated by
intramolecular autophosphorylation as reported previously
(Behn-Krappa and Newton, 1999), we analysed the phos-
phorylation status of various PKCa mutants. The PKCa con-
struct that contains only C-terminal fragment (amino acid
603–672) was phosphorylated on TM but not HM when
expressed in 293T cells (Figure 3A). Interestingly, phospho-
rylation of TM, HM and A-loop were all decreased in PKCa
kinase-deficient mutant (K368R) (Figure 3B), whereas phos-
phorylation of Akt TM was comparable in both wild-type and
kinase-inactive Akt (data not shown) (Alessi et al, 1996).
These data suggest that TM in both PKCa and Akt is not
directly phosphorylated by intramolecular autophosphoryla-
tion. However, it is possible that kinase activity of PKCa is
important for the overexpressed full-length PKCa to sustain
proper localization or conformation to become a substrate for
phosphorylation. Interestingly, PKCa HM phosphorylation
was reduced but considerably sustained in A-loop mutant
(T497A), whereas it was abolished in PDK1/ ES cells
(Figures 2C and 3B). These data suggest that a PDK1- and
mTORC2-dependent heterologous kinase could be involved in
phosphorylation of HM in PKCa in addition to the proposed
intramolecular autophosphorylation (Behn-Krappa and
Newton, 1999). Together, the above data indicate that
the PKCa and Akt TM are likely to be regulated by a
Rictor/Sin1-dependent heterologous kinase, but not by
autophosphorylation.
We investigated the relationship between TM and
HM phosphorylation in PKCa by examining TM and
HM mutants. We found that phosphorylations of the TM
and HM were independent from each other, as mutation in
one motif did not affect phosphorylation of the other
(Figure 3C).
Rictor and Sin1 regulate some but not all PKC family
members
The diverse PKC isoforms are differentially regulated. We
wanted to determine which PKCs are regulated by Rictor and
Sin1. Both protein levels and mobility of PKCa and PKCe,
but not PKCd and PKCl, were dramatically altered in
Rictor/ or Sin1/ cells (Figure 4A). Consistent with
the above-mentioned observation, TM phosphorylation of
PKCd was slightly changed in both Sin1/ cells
(Figure 2A) and Rictor/ cells (data not shown). These
TORC2 in PKC and Akt phosphorylation
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data indicate that Rictor and Sin1 are required for
phosphorylation and protein levels of PKCa and PKCe, but
not PKCd or PKCl.
To examine additional PKC family members,
Rictorþ /þ or / MEF cells were transfected with
plasmids encoding various isoforms of PKC. We found that
protein levels of all cPKCs were much lower in the Rictor/
cells than those in the Rictorþ /þ cells (Figure 4B).
Furthermore, the residual cPKCs in the Rictor/ cells
showed a faster mobility, indicative of hypophosphorylation
of these proteins. Among the three nPKC isoforms (d, e and
Z) tested, only PKCe protein levels and mobility were af-
fected. Rictor deletion had little effect on the protein levels
and mobility of the aPKCl (Figure 4A) and aPKCz
(Figure 4B). Our data reveals that Rictor and Sin1 are
required for phosphorylation and protein levels of all cPKCs
and nPKCe.
mTORC2 is involved in TM and HM phosphorylation
of PKCa and Akt
The fact that both Rictor and Sin1, two known mTORC2
components, are required for the phosphorylation of TM
and HM in both PKCa and Akt indicates a possible involve-
ment of mTORC2 in these phosphorylations. We utilized
mTOR inhibitors to explore a possible function of mTORC2
in the regulation of PKCa and Akt phosphorylation. Cells
were treated with rapamycin (to inhibit mTORC1), LY294002
(to inhibit both PI3K and mTOR) and wortmannin (to inhibit
PI3K) for 1 h (Brunn et al, 1996). As expected, rapamycin
selectively decreased the HM phosphorylation of S6K
(Supplementary Figure S2A). Both LY294002 and wortman-
nin inhibited phosphorylation of the A-loop and HM in Akt
but not PKCa. However, TM phosphorylation in both PKCa
and Akt was resistant to LY294002. LY294002 treatment for




























































































Figure 2 Sin1 but not PDK1 is required for PKCa and Akt TM phosphorylation. (A) Phosphorylation of the TM and HM in PKCa and Akt, but
not PKCd and S6K, is eliminated in Sin1/ MEF. Sin1þ /þ or / MEF cells were cultured in normal medium (medium), serum-free
medium for 12 h (starved) or restimulated with serum for 30min (serum). Immunoblottings were performed using indicated antibodies.
(B) Reintroduction of Sin1 in Sin1/ MEF restores phosphorylation. Sin1/ MEFs were infected with either empty vector or
HA-Sin1-containing retroviruses. The cells were treated with or without 400nM insulin for 30min. (C) PDK1 is required for PKCa HM but
not TM phosphorylation. Immunoblotting of lysates from PDK1þ /þ and/ ES cells was performed for PKCa and Akt phosphorylation. The
cells were serum-starved for 3 h and then stimulated with or without 100 nM IGF for 30min in the presence or absence of pretreatment
with 100 nM wortmannin (W) for 30min.
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PKCa phosphorylation (Supplementary Figure S2B). These
results indicate that mTOR might not be involved in PKC
phosphorylation. Alternatively, mTOR is involved, but the
effect of mTOR inhibition on PKCa phosphorylation is
masked by the high stability of PKC phosphorylation.
As the TM phosphorylation residues in PKCa and AKT are
followed by a proline, we tested a possible role of proline-
directed protein kinases. Twenty-four-hour treatment with
inhibitors for ERK, JNK, p38, CDK, GSK3 and CK2 had no
significant effect on Akt phosphorylation, whereas LY294002
inhibited Akt TM and HM phosphorylation (Supplementary
Figure S2C). These results argue against the involvement of
these proline-directed kinases in Akt TM phosphorylation.
Prolonged rapamycin treatment has been reported to dis-
rupt mTORC2 assembly and function in several cell lines
(Sarbassov et al, 2006). We found that prolonged rapamycin
treatment indeed disrupted mTORC2 in HepG2 cells as de-
termined by co-immunoprecipitation of mTOR with
Rictor (Figure 5A). Rapamycin treatment for 72 h caused a
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Figure 3 Relationship among different PKCa phosphorylation sites. (A) Kinase domain is not required for PKCa TM phosphorylation.
HEK293Tcells were transfected with indicated GST–PKCa full length or C-terminal fragment (CT, a.a. 603–672). Cell lysates were probed with
antibody for GST, TM and HM as indicated. (B) Phosphorylation status of PKCa mutants. Transfected HA-tagged PKCa (in HEK293T) were
immunoprecipitated with HA-antibody. Phosphorylation was determined by immunoblotting with indicated antibodies. K368R and T497A
denote PKCa kinase inactive and A-loop mutant, respectively. (C) Relationship between PKCa TM and HM phosphorylation. HEK293T cells
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Figure 4 Effect of Rictor and Sin1 deletion on PKC isoforms. (A) Protein levels of PKCa and e but not PKCd and l are decreased in Rictor or
Sin1/ MEFs. Expression levels of endogenous PKCs were monitored by immunoblotting. (B) Expression levels of transfected PKC isoforms
in Rictorþ /þ and / MEFs. The Rictorþ /þ and / MEFs were transfected with HA–PKC isoforms as indicated. Expression levels and
mobility of the transfected PKCs were monitored by HA antibody.
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In contrast, the interaction between Rictor and Sin1 was not
affected by rapamycin. Rapamycin treatment for 72 h signifi-
cantly decreased both TM and HM phosphorylation in Akt
and PKCa (Figure 5A). In contrast, rapamycin treatment had
limited effect on TM and HM phosphorylation in PKCa and
on TM in Akt phosphorylation in A549 cells whose mTORC2
function was reported to be insensitive to rapamycin
(Supplementary Figure S2D) (Sarbassov et al, 2006). These
observations support a possible role of mTORC2 in PKCa and
Akt regulation.
The inability of transient mTOR inhibition to abolish PKCa
phosphorylation is likely due to the fact that the PKCa
phosphorylation is extremely stable. To further test this
possibility, we next examined the phosphorylation of newly
synthesized PKCa. HEK293T cells were transfected with GST-
tagged PKCa and Akt in a medium containing PI-103, which is
a potent inhibitor of PI3K and mTOR (Fan et al, 2006; Knight
et al, 2006). Interestingly, the TM and HM phosphorylation of
the transfected GST–PKCa and Akt were dramatically re-
duced by PI-103 (Figure 5B). These results indicate that
mTOR is required for TM and HM phosphorylation of the
newly synthesized PKCa. To further investigate the function
of mTOR in PKCa phosphorylation, we ablated mTORC2








































































Figure 5 mTORC2 integrity and mTOR kinase activity are required for PKCa and Akt TM phosphorylation. (A) Prolonged treatment of
rapamycin decreases both TM and HM phosphorylation in PKCa and Akt. HepG2 cells were treated with 100nM rapamycin for indicated times.
Total cell lysates were probed with PKC and Akt antibodies as indicated. Rictor or mTOR immunoprecipitates were analysed by immunoblotting
with antibodies against TORC2 components. (B) The PI3K/mTOR inhibitor P103 inhibits phosphorylation of transfected PKCa and Akt.
HEK293T cells were transfected with GST–PKCa and GST–Akt in the presence or absence of 10mM PI-103. Immunoblottings were performed
using indicated antibodies. (C) mTOR and Rictor are required for maintaining both phosphorylation and protein level of PKCa. HeLa
cells stably expressing control, mTOR shRNA or Rictor shRNA were transfected with control, mTOR or Rictor siRNA oligos, respectively.
(D) Knockdown of mTOR combined with prolonged rapamycin treatment abolishes TM phosphorylation. HeLa cells with mTOR knockdown
using shRNA-containing lentivirus were pretreated with 100nM rapamycin for 24 h. mTOR siRNA oligos together with GST–PKCa, GST–Akt,
and siRNA-resistant Myc-mTOR were transfected as indicated under rapamycin treatment. (E) Kinase activity of mTOR is required for PKCa TM
phosphorylation. Experiments were similar to Figure 5D except that the siRNA-resistant kinase dead (KD) mTOR was included. Protein levels
and phosphorylation of both the transfected GST–PKCa and the endogenous PKCa were determined.
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of either mTOR or Rictor significantly decreased PKCa TM
phosphorylation and protein level (Figure 5C).
It has been reported that combination of mTOR knock-
down with prolonged rapamycin treatment efficiently inhibits
mTORC2 function (Sarbassov et al, 2006). HeLa cells with
shRNA-mediated mTOR knockdown were pretreated with
rapamycin for 24 h and then transfected with PKCa or Akt
plasmid. We found that phosphorylation of GST–PKCa TM
was completely abolished and that phosphorylation of the
HM was dramatically reduced (Figure 5D), results similar to
those observed in the Rictor/ or Sin1/ cells (Figures 1
and 2A). Moreover, phosphorylation of the transfected Akt
was inhibited by the combinatory treatment with mTOR
knockdown and rapamycin (Figure 5D). The combination
of mTOR knockdown and rapamycin treatment also signifi-
cantly decreased the TM and HM phosphorylation of endo-
genous PKCa (Figure 5E). In contrast, phosphorylation of
neither the endogenous ERK nor PKCd was affected
(Supplementary Figure S2E), indicating that the above-men-
tioned treatment was specific towards Akt and PKCa. Co-
transfection of the siRNA-resistant wild-type mTOR, but not
kinase-deficient mTOR, restored the GST–PKCa TM phos-
phorylation (Figure 5D and E), indicating that mTOR kinase
activity is important for PKCa TM and HM phosphorylation.
On the basis of these results, we conclude that mTORC2 has
an essential role for the TM and HM phosphorylation of both
PKCa and Akt.
PKCa was not directly phosphorylated by mTORC2
in vitro but associated with Rictor
To test whether mTORC2 could phosphorylate TM in PKCa
and Akt, we performed in vitro kinase assays with immuno-
precipitated mTOR or Rictor. The immunoprecipitated mTOR
or Rictor complex could phosphorylate the HM of His–Akt
protein, which was prepared from baculovirus (Figure 6A).
We consistently observed that IP complex with mTOR anti-
body could phosphorylate Akt HM more efficiently than
that with Rictor antibody, even though the amount of
precipitated Rictor was similar. This observation could be
explained that not all Rictor in the cell is associated with
mTOR. Alternatively, we cannot exclude the possibility that
the Rictor antibody may partially interfere with the mTORC2
kinase activity.
As the commercial His–Akt was phosphorylated on TM
(Figure 6A), we prepared GST–Akt from E. coli as a substrate.
Immunoprecipitated mTOR could phosphorylate the HM but
not TM of GST–Akt (Figure 6B). In contrast, the immunopre-
cipitated mTOR or Rictor did not phosphorylate the
GST–PKCa prepared from E. coli.
To exclude the possibility that PKCa and Akt proteins
purified from bacteria may not be suitable substrates for
mTORC2, we prepared dephosphorylated full-length PKCa
and Akt from HeLa cells. GST–PKCa and GST–Akt were
transfected into the HeLa cells with the combinatory treat-
ment of mTOR knockdown and rapamycin. The purified
GST–PKCa and GST–Akt indeed had little phosphorylation
on either TM or HM (Figure 6C) and were used as substrates
in the in vitro kinase reaction. Immunoprecipitated mTOR
could only phosphorylate HM but not TM in GST–Akt
(Figure 6C). Furthermore, neither TM nor HM in GST–PKCa
was phosphorylated by the immunoprecipitated mTOR.
These results suggest that mTORC2 may not be the kinase
directly responsible for the TM phosphorylation in PKCa and
Akt. However, our study cannot exclude the possibility that
the immunoprecipitated mTORC2 misses a critical compo-
nent required to phosphorylate the TM of PKCa and Akt in
vitro or the substrates may miss some modifications or
correct folding that are essential for the in vitro phosphoryla-
tion by mTORC2.
We tested the interaction between Rictor or Sin1 and PKCa
by co-immunoprecipitation. We observed that transfected
PKCa was co-immunoprecipitated with transfected Rictor
(Figure 6D). It is worth noting that much less PKCa was co-
immunoprecipitated with Sin1. This result suggests that the
interaction between Sin1 and PKCa could be indirectly
mediated by the endogenous Rictor. In contrast, transfected
PKCa was not co-immunoprecipitated with the mTORC1
component Raptor (Supplementary Figure S3). We observed
that the faster migrating hypophosphorylated PKCa was
preferentially precipitated with Rictor (Figure 6D).
Immunoblotting with phosphospecific antibodies for TM
and HM confirmed that the Rictor-co-immunoprecipitated
PKCa was hypophosphorylated (Figure 6D). It has been
suggested that the newly synthesized PKC is unphosphory-
lated and phosphorylation is critical for PKC maturation
(Newton, 2003). Therefore, our data indicate that Rictor
may contribute to PKC phosphorylation and maturation by
directly associating with the unphosphorylated immature
PKC.
PKCa is unstable in Rictor/ and Sin1/cells
Next, we investigated the underlining mechanisms for the
dramatic decrease of PKCa protein levels in the Rictor/
and Sin1/ cells. The fact that the protein expression level
of transfected HA-PKCa was also lower in the Rictor/ than
that in the Rictorþ /þ cells (Figure 4B) suggests that Rictor
and Sin1 may regulate the expression of PKCa at the post-
transcriptional level. Surprisingly, we found that PKCa in
Sin1/ cells was stable under cycloheximide treatment
(Figure 7A).
It has been reported that dephosphorylation of the TM may
allow PKC to associate with heat shock protein (Hsp) (Gao
and Newton, 2002), which presumably stabilizes PKC.
Consistent with this notion, inhibition of Hsp90 by radicicol
selectively destabilized both PKCa and PKCe in the Rictor/
cells but not in the Rictorþ /þ cells (Figure 7B). Similar
observations were made with 17-allylamino-17-demethoxy-
geldanamycin (17-AAG), another Hsp90 inhibitor
(Supplementary Figure S4). We observed that inhibition of
Hsp90 also destabilized Akt more significantly in Rictor/
cells than þ /þ cells (data not shown). These results in-
dicate that the residual unphosphorylated PKCa in Rictor/
cells is stabilized by Hsp90.
To clarify whether TM or HM phosphorylation is respon-
sible for PKCa instability induced by Hsp90 inhibitor,
HEK293T cells were transfected with wild-type, TM mutant
(T638A) or HM mutant (S657A) and treated with radicicol.
Interestingly, only TM mutant T638A was significantly desta-
bilized by radicicol (Figure 7C), suggesting that Hsp90 is
particularly important for PKCa stability when TM is not
phosphorylated.
The destabilization of PKCa in Rictor/ cells by Hsp
inhibitors, however, cannot explain why PKCa protein level is
much lower in the Rictor/ cells even in the absence of Hsp
TORC2 in PKC and Akt phosphorylation
T Ikenoue et al
&2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 14 | 2008 1925
inhibitors. To determine the whereabouts of PKCa in
Rictor/ cells, MG132 was used to inhibit proteasome-
dependent degradation. Surprisingly, MG132 treatment did
not increase PKCa in Rictor/ cells (data not shown).
Therefore, we examined whether the unphosphorylated
PKCa might be accumulated in insoluble fraction, which
would not be detected by the extraction methods used in
the above analyses. Interestingly, MG132 did cause a dra-
matic accumulation of PKCa in the insoluble fraction in
Rictor/ cells, but not in Rictorþ /þ cells, even though
the þ /þ cells had a higher level of total PKCa (Figure 7D).
Furthermore, the insoluble PKCa showed a high molecular
weight ladder in the Rictor/ cells, indicative of ubiquiti-
nation. These observations indicate that the unphosphory-
lated PKCa is unstable and rapidly degraded by the
proteasome pathway. When proteasome activity is inhibited,
the unphosphorylated PKCa is ubiquitinated and accumu-
lated in insoluble fraction.
Lack of TM phosphorylation in PKCa causes
ubiquitination, degradation and aggresome formation
We determined ubiquitination of wild-type PKCa, PKCa
T638A (TM mutation), PKCa T631A/T638A (mutation of
the TM and the compensation site T631) (Edwards et al,
1999), PKCa S657A (HM mutation) and PKCa T638A/S657A
(TM and HM double mutation) by transfection into HEK293
cells. We found that PKCa TM mutant (T638A), but not the
HM mutant (S657A), was more ubiquitinated compared with
wild-type protein in the presence of MG132 (Figure 7E).
T631A/T638A and T638A/S657A mutants showed further
increase in ubiquitination. These data strongly support the
idea that the TM phosphorylation is important in preventing
PKCa ubiquitination and degradation.
We also determined whether the phosphorylation-defec-
tive PKCa mutants are more prone to partition in the inso-
luble fraction. Fractionation followed by immunoblotting








































































Figure 6 PKCa is not directly phosphorylated by mTORC2 in vitro but associated with Rictor. (A–C) Immunoprecipitated mTORC2 fails to
phosphorylate PKCa in vitro. Endogenous proteins from HeLa cells were immunoprecipitated with control, mTOR or Rictor antibody. The
immunoprecipitates were used to phosphorylate GST–PKCa (CT) purified from E. coli and His–Akt (FL: full-length) from baculovirus (A),
GST–Akt (CT) from E. coli (B) or GST–Akt and GST–PKCa from HeLa cells (C), which had mTOR knockdown and rapamycin treatment. FL and
CT denotes full-length and C-terminal fragment (a.a. 125–480 for Akt and a.a. 322–672 for PKCa), respectively. **Denotes the non-specific
signal detected by phospho-Akt HM antibody. (D) Rictor preferentially interacts with hypophosphorylated PKCa. HEK293 cells were transfected
with HA–PKCa and Myc–Rictor, Myc–Sin1 or empty vector as indicated. Cell lysates were immunoprecipitated with Myc antibody, and then
co-immunoprecipitated HA–PKCa was determined by immunoblotting. The transfected PKCa migrates as doublet. The slow-migrating PKCa
(phosphorylated form) and fast-migrating PKCa (hypophosphorylated form) are denoted by two asterisks and a dash, respectively. The faster
migrating HA–PKCa was co-immunoprecipitated with Myc–Rictor (SE denotes short exposure). Longer exposure (LE) shows that a small
amount of PKCa was co-immunoprecipitated with Myc–Sin1. Phosphorylation of the co-immunoprecipitated HA–PKCa was determined with
indicated phospho-PKCa antibodies (right panels).
TORC2 in PKC and Akt phosphorylation
T Ikenoue et al
The EMBO Journal VOL 27 | NO 14 | 2008 &2008 European Molecular Biology Organization1926
wild-type PKCa was present in the insoluble fraction upon
MG132 treatment (Figure 7F). This observation was different
from the endogenous PKCa, which had little in the insoluble
fraction even in the presence of MG132 (Figure 7D). This
difference can be explained by the fact that the transfected
PKCa was not fully phosphorylated (Figure 6D). Consistently,
only the fast-migrating, hence unphosphorylated, PKCa was
preferentially partitioned in the insoluble fraction (Figure 7F).
As expected, PKCa TM mutants were more prone to be found
in the insoluble fraction. These data are consistent with a
model wherein phosphorylation of TM stabilizes PKCa,
whereas the unphosphorylated protein is rapidly ubiquiti-
nated, thus targeted for degradation.
Proteasome-mediated degradation is the major pathway
for clearance of intracellular misfolded proteins. Inhibition of
proteasome often induces aggresome formation, which
shows a perinuclear localization. We found that MG132
caused a marked perinuclear localization of PKCa TM mutant
(T631A/T638A), but not the wild-type PKCa (Figure 7G). To
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Figure 7 TM phosphorylation protects PKCa from proteasome-dependent degradation. (A) The residual PKCa in Sin/ MEF cells is stable.
Cells were treated with 100 mg/ml cycloheximide (CHX) for the indicated time. PKCa protein levels were determined. (B) Inhibition of Hsp90
destabilizes PKCa and PKCe in Rictor/ but not in þ /þ MEFs. Cells were treated with 20mM radicicol, an Hsp90 inhibitor, for the indicated
time, and PKC protein levels were monitored by immunoblotting. (C) Mutation of the TM phosphorylation site destabilizes PKCa in the
presence of Hsp90 inhibition. HEK293 cells transfected with HA–PKCawild type, TM mutant (T638A) or HMmutant (S657A) were treated with
20mM radicicol for the indicated time. The protein levels of HA–PKCa were monitored by immunoblotting. (D) Inhibition of proteasome
accumulates insoluble PKCa in the Rictor/ but not þ /þ cells. Cells were treated with 10mM MG132 for 12 h, lysed in NP-40 buffer and
then fractionated into soluble (S) and insoluble fractions (P). (E) Mutation of the PKCa TM phosphorylation site enhances ubiquitination.
HEK293 cells were transfected with HA–PKCa wild type (WT), TM mutant (T638A), TM and compensation site mutant (T631A/T638A), HM
mutant (S657A) or TM and HM mutant (T638A/S657A) together with FLAG–Ub. The transfected cells were treated with or without 10mM
MG132 for 12 h as indicated. Soluble fractions were immunoprecipitated with anti-HA, and ubiquitinated PKCa was determined by
immunoblotting using anti-FLAG antibody. (F) The TM mutant PKCa is more prone to be in the insoluble fraction. HEK293 cells were
transfected with HA–PKCa WTand TM mutants and treated with 10mM MG132 for 12 h as described in Figure 6D. The levels of HA–PKCa in
both soluble and insoluble fractions were determined by immunoblotting using anti-HA antibody. P and S denote insoluble pellet and soluble
fractions, respectively. (G) PKCa TM mutant, but not the wild type, accumulates in aggresome when proteasome is inhibited. HeLa cells
transfected with wild-type or mutant HA–PKCa (T631A/T638A) were treated with 5 mM MG132 for 24 h. Double immunofluorescent staining
was performed using anti-HA antibody for HA–PKCa (red colour) and anti-Ub antibody for conjugated ubiquitin (green colour).
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antibody against conjugated ubiquitin, which is an aggre-
some marker. In the presence of MG132, the PKCa TM
mutant was co-localized with the aggresome marker.
Rictor/ cells are defective in PKC signalling
and kinase activity
Phorbol esters, such as PMA, and their derivatives, such as
thymeleatoxin (TX), are potent activators for cPKCs and
nPKCs. We tested PKC activation in Rictor/ cell by exam-
ining phosphorylation of PKC substrates in response to
stimulation of TX. TX treatment caused a rapid and robust
increase in phosphorylation of PKC substrates (Figure 8A).
PKC substrate phosphorylation was blocked by bisindolylma-
leimide I (BIM), a PKC inhibitor. Importantly, phosphoryla-
tion of PKC substrates was significantly diminished in
Rictor/ cells (Figure 8A), suggesting that PKC signalling
is compromised in the Rictor/ cells. The partial increase
of PKC substrate phosphorylation was probably due to the
activation of nPKCs by TX in the Rictor/ cells because
nPKCd and nPKCZ are not regulated by Rictor (Figure 4B). It
is also possible that the PKC substrate antibody may recog-
nize proteins phosphorylated by other kinases. Moreover,
phosphorylation of MARCKS (myristoylated, alanine-rich
PKC substrate) (Stumpo et al, 1989) was lower in the
Rictor/ cells than that in the Rictor þ /þ cells. We also
observed that the duration of MARCKS phosphorylation was
significantly shorter in Rictor/ MEFs than that in
Rictorþ /þ MEFs (Figure 8B). Similar results were observed
in the Sin1/ MEFs (Supplementary Figure S5A). On the
basis of these results, our data indicate that PKC signalling is
compromised in either Rictor/ or Sin1/ cells.
Membrane translocation of PKC by PMA is important
for PKC activation and phosphorylation of PKC
substrates (Newton, 2003). We examined whether the
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Figure 8 PKCa functions are compromised in Rictor and Sin1/ cells. (A) Phosphorylation of PKC substrates induced by thymeleatoxin (TX)
is diminished in Rictor/ MEFs. Rictorþ /þ and / MEFs were treated with 100nM thymeleatoxin (an activator for cPKC and nPKC). The
presence of 1 mM bisindolylmaleimide I (BIM, pan PKC inhibitor) is indicated. Total cell lysates were prepared and immunoblotting was
performed with indicated antibodies. (B) PMA-induced MARCKS phosphorylation is compromised in Rictor/ cells. Cells were treated with
400nM PMA. Immunoblottings were performed with indicated antibodies. (C) Effect of PMA on PKCa translocation in Rictorþ /þ and /
MEFs. Cells were treated with 400nM PMA for 30min. Subcellular fractionation was performed. PKCa protein was detected by immunoblot-
ting. (D) Mutation of TM and HM in PKCa abolishes kinase activity. HeLa cells were transfected with PKCa WT, kinase inactive (K368R) and
TM and HM mutants (T638A/S657A). HA–PKCa was immunoprecipitated and kinase activity was measured using a synthetic peptide as a
substrate and radioactive ATP. (E) PKCa expressed in Sin1/ MEFs is inactive. Sin1þ /þ and / MEFs were transfected with various
concentrations of HA–PKCa. HA–PKCa was immunoprecipitated and kinase activity was measured similar to Figure 7D.
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hypophosphorylated PKCa could respond to PMA treatment.
As expected, PMA caused a complete translocation of PKCa
from cytosol to membrane- and detergent-insoluble fractions
in Rictorþ /þ cells (Figure 8C). In contrast, the Rictor/
cells had a basal level of membrane-associated PKCa. Upon
PMA stimulation, the cytosolic PKCawas mainly translocated
to detergent-insoluble fraction with little being translocated
to the membrane fraction (Figure 8C). These data show that
Rictor is important for proper PKCa activation in response to
intracellular second messenger. In the Rictor/ or Sin1/
cells, PKCa migrated as a doublet and was downshifted by
PMA treatment. We found that sustained PMA treatment
caused a dramatic downregulation of PKCa in Sin1þ /þ
but not / cells (Supplementary Figure S5), indicating
that the PKCa did not properly respond to PMA.
We next investigated the importance of TM and HM
phosphorylation in PKCa kinase activity. In vitro kinase
assay showed that PKCa with mutation of both the TM
and HM phosphorylation sites had little kinase activity
(Figure 8D). To directly determine the function of
phosphorylation in PKC activity, HA–PKCa was expressed
in Sin1þ /þ and / cells. We found that HA–PKCa pre-
cipitated from Sin1/ cells had a much lower kinase
activity than that from the Sin1þ /þ cells (Figure 8E). The
HA–PKCa precipitated from Sin1/ cells also showed a
faster migration than that from the Sinþ /þ cells. The
above-mentioned data demonstrate that the Rictor/Sin1-
dependent phosphorylation of TM and HM is essential for
PKCa kinase activity and signalling.
Discussion
Phosphorylation of three conserved sites (A-loop, TM and
HM) is essential for the function of PKC and other AGC family
kinases, including Akt and S6K (Hauge et al, 2007). However,
key differences exist between PKC and Akt. Phosphorylation
of both A-loop and HM in Akt is regulated by stimulation and
serves as the major input for Akt activation in response to
extracellular signals. For example, mitogenic growth factors
stimulate phosphorylation of both A-loop and HM in Akt. In
contrast, phosphorylations of all three sites in PKC are
constitutive, whereas binding of second messengers, such
as DAG and calcium, to regulatory domain provides the major
signal input for PKC activation (Parekh et al, 2000; Newton,
2003). Then, what are the physiological functions of PKC
phosphorylation, especially the TM site?
Our study supports the essential function of TM and HM
phosphorylation in PKCa kinase activity, consistent with
previous reports (Zhang et al, 1994; Edwards et al, 1999).
In vitro kinase assays show that the unphosphorylated HA–
PKCa expressed in Sin1/ cells had little activity. Although
both TM and HM are highly conserved in PKC family, it is not
fully understood how phosphorylation of these two motifs
is controlled. Previous studies reported that TM and HM
phosphorylation of cPKCs and nPKCe were controlled by
autophosphorylation. Growth factor-dependence HM phos-
phorylation was reported in nPKCe, whereas other reports
showed that HM phosphorylation of cPKCa, nPKCd and
nPKCe are rapamycin sensitive and aPKCz is the possible
HM kinase for PKCd (Behn-Krappa and Newton, 1999; Parekh
et al, 1999; Ziegler et al, 1999; Cenni et al, 2002).
In this study, we demonstrate the functional importance of
mTORC2 in the TM and HM phosphorylation of Akt and some
PKCs (Supplementary Figure S6). Rictor, Sin1 and mTOR,
hence mTORC2, are essential for TM phosphorylation of
PKCa and likely for PKCb I, b II, g, e. Inactivation of
mTORC2 also decreases but does not abolish HM phospho-
rylation in PKCa; therefore, mTORC2 is more important for
PKCa TM than HM phosphorylation. In addition, we pre-
sented data that mTORC2 is also essential for Akt TM
phosphorylation. Our study demonstrates that intramolecular
autophosphorylation is not required for PKCa TM phosphor-
ylation.
It has been proposed that phosphate at the TM site in AGC
kinases, including Akt and PKC, interacts with surrounding
basic residues to be protected from dephosphorylation
(Hauge et al, 2007). On the basis of our data, the phosphor-
ylation on TM and HM in PKCa and Akt with the exception of
Akt HM is rather stable. However, several lines of evidence
presented in this study are consistent with a model wherein
mTORC2 integrity and kinase activity are important for TM
and HM phosphorylation of both PKCa (Supplementary
Figure S6) and Akt. First, genetic ablation of Rictor or Sin1
strongly inhibits these phosphorylations. Second, disruption
of mTORC2 assembly by rapamycin treatment or inhibition of
mTORC2 kinase activity by inhibitors reduces the TM and HM
phosphorylation in PKCa and Akt, especially the newly
synthesized proteins. Third, knockdown of mTOR in combi-
nation with rapamycin treatment strongly inhibits the phos-
phorylation of both PKCa and Akt, especially on their TM
site. We propose that mTORC2-mediated PKCa TM phosphor-
ylation occurs during its maturation process and contributes
to PKCa maturation and stability (Supplementary Figure S6).
Genetic studies in yeast have implicated a role of TOR in
phosphorylation of the AGC family kinases (Kamada et al,
2005). Our data demonstrate that mTOR kinase activity is
required for the phosphorylation of PKCa TM and HM and
corresponding sites in Akt. However, it is worth noting that
our study has yet to establish a direct phosphorylation of
PKCa TM and HM and Akt TM by mTORC2. We speculate
that mTORC2 may activate a kinase(s) that is responsible for
PKC and Akt phosphorylation (Supplementary Figure S6).
However, these data cannot exclude the possibility of autop-
hosphorylation being responsible for PKCa HM. It is also
possible that mTORC2 may directly phosphorylate the TM
and HM in PKCa and Akt in vivo, but our in vitro kinase
reaction could not duplicate the in vivo conditions.
Regardless of the biochemical mechanism, our results have
established an important novel function of mTORC2 in the
phosphorylation and signalling of cPKCs, nPKCe and Akt.
The reduced PKCa expression in Rictor/ cells is due to
protein instability. On the basis of our data, we propose the
following model. In wild-type cells, the newly synthesized
PKCa is rapidly phosphorylated and then folded into a correct
conformation, which is stable and ready for activation by
second messengers. Phosphorylation of TM in PKCa is parti-
cularly important for this maturation process. In Rictor/
or Sin1/ cells, the newly synthesized PKCa is not phos-
phorylated. The unphosphorylated PKCa is rapidly ubiquiti-
nated and then degraded by the proteasome (Leontieva and
Black, 2004). This model is supported by our data that
inhibition of proteasome by MG132 results in accumulation
of ubiquitinated PKCa in the insoluble fraction in the
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Rictor/, but not in the þ /þ , cells (Figure 7D and E). The
unphosphorylated and ubiquitinated PKCa accumulates in
aggresome when proteasome-mediated degradation is
blocked (Figure 7G).
A small fraction of unphosphorylated PKCa in Rictor/
cells may escape the degradation and exist in a form that is
stable but defective for signalling, such as response to PMA
stimulation. The unphosphorylated PKCa is stabilized by
Hsp. It is well established that activation of PKCa results in
dephosphorylation (Parekh et al, 2000; Newton, 2003).
Furthermore, prolonged PMA treatment causes PKCa down-
regulation due to ubiquitination and degradation. DAG, the
physiological activator, has a much shorter half-life than
PMA. Therefore, the activation of PKCa under physiological
conditions is rather transient. It has been reported that the
temporarily dephosphorylated PKCa after physiological acti-
vation, however, is rephosphorylated and quickly replenish
cellular mature PKCa pool ready for subsequent stimulations
(Newton, 2003). We hypothesize that mTORC2 not only
contributes to the maturation of newly synthesized PKCa
but may also have an important function in facilitating the
rephosphorylation of the signal-induced and dephosphory-
lated PKCa.
Among the PKCs tested, the protein levels of cPKCs and
nPKCe depend on mTORC2. In contrast, protein levels of
PKCd, l, Z and z are not affected by Rictor deletion, indicat-
ing that phosphorylation and maturation of these PKCs are
regulated by different mechanisms. We also established that
TORC2 is essential for the TM phosphorylation in Akt. One
may speculate that other AGC family kinases are also regu-
lated by either mTORC1 or mTORC2. Furthermore, we pro-
pose that phosphorylation of the conserved TM motif most
probably has a similar function (facilitating protein matura-
tion and stability) in other members of the AGC family
kinases. This study demonstrated a novel function of
mTORC2 in protein kinase maturation and revealed that
mTORC2 has a much broader physiological function signifi-
cantly beyond the current knowledge as the kinase phosphor-
ylating Akt HM.
Materials and methods
Plasmids, antibodies and chemicals
Mammalian expression constructs of HA-tagged various PKC
isoforms (a, bI, bII, g, d, e, Z, z) were kind gifts from Shun’ichi
Kuroda (Osaka University) and Jae-Won Soh (Inha University).
pPGS–HA–PKCa and pEBG–PKCa were created by subcloning rat
PKCa cDNA into pPGS–CITE–neo-HA and pEBG vector. pRK7-GST–
PKCa-CT was created by amplifying the C-terminal fragment
(a.a. 603–672) and subcloning it into pRK7–GST vector.
PKCa point mutant constructs were created using site-directed
mutagenesis. shRNA lentivirus constructs and siRNA oligos were
purchased from Addgene and Dharmacon, respectively. MARCKS
antibody was kindly provided by Perry J Blackshear (National
Institute of Environmental Health Sciences). Tubulin and FLAG
(M2) antibodies were purchased from Sigma. PKCd, e, l and Hsp90
antibodies were from BD Biosciences. HA and Myc antibodies were
obtained from Covance. The conjugated ubiquitin antibody was
from BIOMOL. Alexa Fluors 594 goat anti-mouse IgG and Alexa
Fluors 488 goat anti-rabbit IgG were from Invitrogen. Other
antibodies used in this study were purchased from Cell Signaling
Technology. Rapamycin was obtained from Sigma. Other chemicals
were from Calbiochem.
Immunoblotting, immunoprecipitation and kinase assay
PDK1þ /þ and / ES cell lysates were kindly provided by Dario
Alessi and Huang Xu (University of Dundee). For immunoblotting
analysis, cells were lysed in NP-40 buffer (10mM Tris–HCl pH 7.5,
100mM NaCl, 1% NP-40, 50mM NaF, 2mM EDTA, 1mM PMSF,
10 mg/ml leupeptin, 10mg/ml aprotinin). Rictor knockout mice
embryos were also lysed in NP-40 buffer. For subcellular fractiona-
tion, Rictor þ /þ and / MEFs were stimulated by PMA
(400nM) for 30min, lysed by sonication in HEPES buffer (50mM
HEPES pH 7.4, 1mM EDTA, 1mM EGTA, 50mM NaF, 1mM DTT,
0.2mM PMSF) and centrifuged at 100 000 g for 30min at 41C. The
supernatant was used as cytosolic fraction, and the pellet was
resuspended in HEPES buffer containing 1% Triton X-100 and
centrifuged (100 000 g, 30min, 41C), and the supernatant (mem-
brane) and pellet (detergent-insoluble) fractions were stored for
further analyses. For preparation of soluble and insoluble fractions,
the cells were lysed in NP-40 buffer and centrifuged (16 000 g,
10min, 41C), and the supernatant was used as soluble fraction. The
pellet was sonicated with 1 SDS sample buffer and used as
insoluble fraction. For immunoprecipitation, cells were lysed in NP-
40 or 0.3% CHAPS buffer as described previously (Yang et al, 2006).
Antibody (1 mg) was added to each reaction and incubated for
90min at 41C followed by 10ml of protein G-sepharose slurry (50%)
for another hour. Immunoprecipitates were washed four times in
the lysis buffer. For kinase assays, after washing with the lysis
buffer, the immunoprecipitates were washed once more with kinase
buffer and then incubated in 15ml kinase assay reaction mix for
30min at 371C. Kinase assay reactions were designed as reported
previously (Sarbassov et al, 2005). The GST–Akt (a.a. 125–480) and
GST–PKCa (a.a. 322–672) purified from E. coli, full-length GST–
PKCa and GST–Akt from mammalian cells, or full-length His6–Akt
from baculovirus (Upstate Biotechnology), were used as substrates.
To terminate the reaction, 5 ml of 4 SDS sample buffer was added
to each reaction. For PKCa kinase assay, PKC kinase assay kit
(Upstate Biotechnology) was used according to the manufacturer’s
instruction.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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